Skip to content

Efficacy observation of acupuncture for dry eye and its effects on depression and anxiety

Efficacy observation of acupuncture for dry eye and its effects on depression and anxiety

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084597
Enrollment
Unknown
Registered
2024-05-21
Start date
2024-05-28
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye related depression and anxiety

Interventions

acupunture group (Study 1):eletroacupunture
sham acupunture group (Study 1):sham acupunture
acupunture group (Study 2):eletroacupunture
sham acupunture group (Study 2):sham acupunture

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Study 1: 1. Patients meeting the diagnostic criteria for DE 2. 8=HAMD-17=17 3. Ages 18-65 years, no gender limit Study 2: 1. Patients meeting the diagnostic criteria for DE 2. 8=HAMA-14=14 3. Ages 18-65 years, no gender limit

Exclusion criteria

Exclusion criteria: Study 1: 1. Combined with other eye diseases (e.g.blepharospasm, conjunctival laxity, strabismus, amblyopia, glaucoma, cataract, fundus disease, etc.); 2. With active eye diseases or a history of eye surgery within three months; 3. Diagnosed with depression before DE or have taken antidepressants within 1 month; 4. With organic mental disorders, depression caused by psychoactive substances and non-addictive substances; 5. With non-specific depression caused by stroke, neurological diseases such as Parkinson's disease or other systemic diseases; 6. Received acupuncture treatment within 1 month; 7. Pregnant or breastfeeding females; 8. With serious systemic diseases such as cardiovascular, cerebrovascular, hepatic, renal, and hematopoietic system and psychiatric disorders; 9. With autoimmune diseases such as Sjögren's syndrome, rheumatoid arthritis, systemic lupus erythematosus, or ankylosing spondylitis; 10. With damaged, ulcerated, infected, or scarred skin at the selected acupuncture points; 11. Allergic to metal or tape. Study 2: 1. Combined with other eye diseases (e.g.blepharospasm, conjunctival laxity, strabismus, amblyopia, glaucoma, cataract, fundus disease, etc.); 2. With active eye diseases or a history of eye surgery within three months; 3. Diagnosed with anxiety before DE or have taken anxiolytics within 1 month; 4. With organic mental disorders, anxiety caused by psychoactive substances and non-addictive substances; 5. With non-specific anxiety caused by stroke, neurological diseases such as Parkinson's disease or other systemic diseases; 6. Received acupuncture treatment within 1 month; 7. Pregnant or breastfeeding females; 8. With serious systemic diseases such as cardiovascular, cerebrovascular, hepatic, renal, and hematopoietic system and psychiatric disorders; 9. With autoimmune diseases such as Sjögren's syndrome, rheumatoid arthritis, systemic lupus erythematosus, or ankylosing spondylitis; 10. With damaged, ulcerated, infected, or scarred skin at the selected acupuncture points; 11. Allergic to metal or tape

Design outcomes

Primary

MeasureTime frame
Patient health questionaire-9 (Study 1);Generalized Anxiety Disorder 7-item (Study 2);

Secondary

MeasureTime frame
Hamilton Depression Scale (Study 1);Ocular Surface Disease Index (Study 1);Non-invasive Tear Breakup Time (Study 1);Schirmer I test (Study 1);Cornea Fluorescein Staining (Study 1);Corneal Sensation (Study 1);Numerical Rating Scale (Study 1);Chinese Dry Eye-Related Quality of Life Scale (Study 1);Generalized Anxiety Disorder 7-item (Study 1);Hamilton Anxiety Scale (Study 1);Blood CCL2, CD14, CD68 levels (Study 1);functional MRI (Study 1);Hamilton Anxiety Scale (Study 2);Ocular Surface Disease Index (Study 2);Non-invasive Tear Breakup Time (Study 2);Schirmer I test (Study 2);Cornea Fluorescein Staining (Study 2);Corneal Sensation (Study 2);Numerical Rating Scale (Study 2);Chinese Dry Eye-Related Quality of Life Scale (Study 2);Patient health questionaire-9 (Study 2);Hamilton Depression Scale (Study 2);Blood CCL2, CD14, CD68 levels (Study 2);functional MRI (Study 1);

Countries

China

Contacts

Public ContactMa Xiaopeng

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

mantou92@126.com+86 21 6438 2181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026